Literature DB >> 9839013

Potent acetylcholinesterase inhibitors: design, synthesis, and structure-activity relationships of bis-interacting ligands in the galanthamine series.

A Mary1, D Z Renko, C Guillou, C Thal.   

Abstract

New galanthamine derivatives, especially bis-interacting ligands 3-5 and 7-9 were prepared in order to interact with the catalytic and the peripheral sites of acetylcholinesterase (AChE). The synthesis, the anticholinesterase activities, and the structure-activity relationships of bis-interacting ligands are reported. Compounds 4d-e were found to be more potent than galanthamine and tacrine in inhibiting AChE.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9839013     DOI: 10.1016/s0968-0896(98)00133-3

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  16 in total

Review 1.  Chemical and biological aspects of Narcissus alkaloids.

Authors:  Jaume Bastida; Rodolfo Lavilla; Francesc Viladomat
Journal:  Alkaloids Chem Biol       Date:  2006

2.  Investigation of the binding mode of (-)-meptazinol and bis-meptazinol derivatives on acetylcholinesterase using a molecular docking method.

Authors:  Qiong Xie; Yun Tang; Wei Li; Xing-Hai Wang; Zhui-Bai Qiu
Journal:  J Mol Model       Date:  2006-01-11       Impact factor: 1.810

3.  Synthesis and biological study of new galanthamine-peptide derivatives designed for prevention and treatment of Alzheimer's disease.

Authors:  Lyubomir T Vezenkov; Dancho L Danalev; Iwan Iwanov; Valentin Lozanov; Atanas Atanasov; Rumyana Todorova; Nikolay Vassilev; Veronika Karadjova
Journal:  Amino Acids       Date:  2022-05-13       Impact factor: 3.520

4.  Back-scattering interferometry: an ultrasensitive method for the unperturbed detection of acetylcholinesterase-inhibitor interactions.

Authors:  Gabrielle L Haddad; Sherri C Young; Ned D Heindel; Darryl J Bornhop; Robert A Flowers
Journal:  Angew Chem Int Ed Engl       Date:  2012-10-04       Impact factor: 15.336

Review 5.  Hybrids: a new paradigm to treat Alzheimer's disease.

Authors:  Manjinder Singh; Maninder Kaur; Navriti Chadha; Om Silakari
Journal:  Mol Divers       Date:  2015-09-02       Impact factor: 2.943

6.  Synthesis, pharmacological assessment, and molecular modeling of acetylcholinesterase/butyrylcholinesterase inhibitors: effect against amyloid-β-induced neurotoxicity.

Authors:  Daniel Silva; Mourad Chioua; Abdelouahid Samadi; Paula Agostinho; Pedro Garção; Rocío Lajarín-Cuesta; Cristobal de Los Ríos; Isabel Iriepa; Ignacio Moraleda; Laura Gonzalez-Lafuente; Eduarda Mendes; Concepción Pérez; María Isabel Rodríguez-Franco; José Marco-Contelles; M Carmo Carreiras
Journal:  ACS Chem Neurosci       Date:  2013-02-04       Impact factor: 4.418

7.  Synthesis and Acetylcholinesterase Inhibitory Evaluation of 4-(1,3-Dioxoisoindolin-2-yl)-N-Phenyl Benzamide Derivatives as Potential Anti-Alzheimer Agents.

Authors:  Ahmad Mohammadi-Farani; Samira Soltani Darbandi; Alireza Aliabadi
Journal:  Iran J Pharm Res       Date:  2016       Impact factor: 1.696

8.  Selective and irreversible inhibitors of aphid acetylcholinesterases: steps toward human-safe insecticides.

Authors:  Yuan-Ping Pang; Sanjay K Singh; Yang Gao; T Leon Lassiter; Rajesh K Mishra; Kun Yan Zhu; Stephen Brimijoin
Journal:  PLoS One       Date:  2009-02-04       Impact factor: 3.240

9.  Synthesis, docking and acetylcholinesterase inhibitory assessment of 2-(2-(4-Benzylpiperazin-1-yl)ethyl)isoindoline-1,3-dione derivatives with potential anti-Alzheimer effects.

Authors:  Ahmad Mohammadi-Farani; Aram Ahmadi; Hamid Nadri; Alireza Aliabadi
Journal:  Daru       Date:  2013-06-07       Impact factor: 3.117

10.  Synthesis and Evaluation of Anti-acetylcholinesterase Activity of 2-(2-(4-(2-Oxo-2-phenylethyl)piperazin-1-yl) ethyl)Isoindoline-1,3-dione Derivatives with Potential Anti-Alzheimer Effects.

Authors:  Alireza Aliabadi; Alireza Foroumadi; Ahmad Mohammadi-Farani; Mahdi Garmsiri Mahvar
Journal:  Iran J Basic Med Sci       Date:  2013-10       Impact factor: 2.699

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.